Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Sharma, AK; Ponery, AS; Lawrence, PA; Ahmed, I; Bastaki, SMA; Dhanasekaran, S; Sheen, RS; Adeghate, E
   Effect of alpha-tocopherol supplementation on the ultrastructural abnormalities of peripheral nerves in experimental diabetes
   JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
   
   A.K. Sharma et al., "Effect of alpha-tocopherol supplementation on the ultrastructural abnormalities of peripheral nerves in experimental diabetes", J PERIPH N, 6(1), 2001, pp. 33-39
2. Obrosova, IG; Van Huysen, C; Fathallah, L; Cao, XH; Greene, DA; Stevens, MJ
   An aldose reductase inhibitor reverses early diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense
   FASEB JOURNAL
   
   I.G. Obrosova et al., "An aldose reductase inhibitor reverses early diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense", FASEB J, 15(13), 2001, pp. NIL_162-NIL_187
3. Obrosova, IG; Stevens, MJ; Lang, HJ
   Diabetes-induced changes in retinal NAD-redox status - Pharmacological modulation and implications for pathogenesis of diabetic retinopathy
   PHARMACOLOGY
   
   I.G. Obrosova et al., "Diabetes-induced changes in retinal NAD-redox status - Pharmacological modulation and implications for pathogenesis of diabetic retinopathy", PHARMACOL, 62(3), 2001, pp. 172-180
4. Pop-Busui, R; Sullivan, KA; Van Huysen, C; Bayer, L; Cao, XH; Towns, R; Stevens, MJ
   Depletion of taurine in experimental diabetic neuropathy: Implications fornerve metabolic, vascular, and functional deficits
   EXPERIMENTAL NEUROLOGY
   
   R. Pop-Busui et al., "Depletion of taurine in experimental diabetic neuropathy: Implications fornerve metabolic, vascular, and functional deficits", EXP NEUROL, 168(2), 2001, pp. 259-272
5. Cotter, MA; Mirrlees, DJ; Cameron, NE
   Neurovascular interactions between aldose reductase and angiotensin-converting enzyme inhibition in diabetic rats
   EUROPEAN JOURNAL OF PHARMACOLOGY
   
   M.A. Cotter et al., "Neurovascular interactions between aldose reductase and angiotensin-converting enzyme inhibition in diabetic rats", EUR J PHARM, 417(3), 2001, pp. 223-230
6. Obrosova, IG; Van Huysen, C; Fathallah, L; Cao, XH; Stevens, MJ; Greene, DA
   Evaluation of alpha 1-adrenoceptor antagonist on diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense
   FASEB JOURNAL
   
   I.G. Obrosova et al., "Evaluation of alpha 1-adrenoceptor antagonist on diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense", FASEB J, 14(11), 2000, pp. 1548-1558
7. Keegan, A; Jack, AM; Cotter, MA; Cameron, NE
   Effects of aldose reductase inhibition on responses of the corpus cavernosum and mesenteric vascular bed of diabetic rats
   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
   
   A. Keegan et al., "Effects of aldose reductase inhibition on responses of the corpus cavernosum and mesenteric vascular bed of diabetic rats", J CARDIO PH, 35(4), 2000, pp. 606-613
8. Yamamoto, Y; Yasuda, Y; Komiya, Y
   Cilostazol prevents impairment of slow axonal transport in streptozotocin-diabetic rats
   EUROPEAN JOURNAL OF PHARMACOLOGY
   
   Y. Yamamoto et al., "Cilostazol prevents impairment of slow axonal transport in streptozotocin-diabetic rats", EUR J PHARM, 409(1), 2000, pp. 1-7
9. Hohman, TC; Cotter, MA; Cameron, NE
   ATP-sensitive K+ channel effects on nerve function, Na+, K+ ATPase, and glutathione in diabetic rats
   EUROPEAN JOURNAL OF PHARMACOLOGY
   
   T.C. Hohman et al., "ATP-sensitive K+ channel effects on nerve function, Na+, K+ ATPase, and glutathione in diabetic rats", EUR J PHARM, 397(2-3), 2000, pp. 335-341
10. Greene, DA; Stevens, MJ; Obrosova, I; Feldman, EL
    Glucose-induced oxidative stress and programmed cell death in diabetic neuropathy
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    D.A. Greene et al., "Glucose-induced oxidative stress and programmed cell death in diabetic neuropathy", EUR J PHARM, 375(1-3), 1999, pp. 217-223
11. Obrosova, IG; Fathallah, L; Lang, HJ; Greene, DA
    Evaluation of a sorbitol dehydrogenase inhibitor on diabetic peripheral nerve metabolism: a prevention study
    DIABETOLOGIA
    
    I.G. Obrosova et al., "Evaluation of a sorbitol dehydrogenase inhibitor on diabetic peripheral nerve metabolism: a prevention study", DIABETOLOG, 42(10), 1999, pp. 1187-1194
12. CALCUTT NA; DINES KC; CESENA RM
    EFFECTS OF THE PEPTIDE HP228 ON NERVE DISORDERS IN DIABETIC RATS
    Metabolism, clinical and experimental
    
    N.A. Calcutt et al., "EFFECTS OF THE PEPTIDE HP228 ON NERVE DISORDERS IN DIABETIC RATS", Metabolism, clinical and experimental, 47(6), 1998, pp. 650-656
13. OHI T; SAITA K; FURUKAWA S; OHTA M; HAYASHI K; MATSUKURA S
    THERAPEUTIC EFFECTS OF ALDOSE REDUCTASE INHIBITOR ON EXPERIMENTAL DIABETIC NEUROPATHY THROUGH SYNTHESIS SECRETION OF NERVE GROWTH-FACTOR/
    Experimental neurology
    
    T. Ohi et al., "THERAPEUTIC EFFECTS OF ALDOSE REDUCTASE INHIBITOR ON EXPERIMENTAL DIABETIC NEUROPATHY THROUGH SYNTHESIS SECRETION OF NERVE GROWTH-FACTOR/", Experimental neurology, 151(2), 1998, pp. 215-220
14. FELDMAN EL; STEVENS MJ; GREENE DA
    PATHOGENESIS OF DIABETIC NEUROPATHY
    Clinical neuroscience
    
    E.L. Feldman et al., "PATHOGENESIS OF DIABETIC NEUROPATHY", Clinical neuroscience, 4(6), 1997, pp. 365-370
15. VANDAM PS; BRAVENBOER B
    OXIDATIVE STRESS AND ANTIOXIDANT TREATMENT IN DIABETIC NEUROPATHY
    Neuroscience research communications
    
    P.S. Vandam e B. Bravenboer, "OXIDATIVE STRESS AND ANTIOXIDANT TREATMENT IN DIABETIC NEUROPATHY", Neuroscience research communications, 21(1), 1997, pp. 41-48
16. BIESSELS GJ; VANDAM PS
    DIABETIC NEUROPATHY - PATHOGENESIS AND CURRENT TREATMENT PERSPECTIVES
    Neuroscience research communications
    
    G.J. Biessels e P.S. Vandam, "DIABETIC NEUROPATHY - PATHOGENESIS AND CURRENT TREATMENT PERSPECTIVES", Neuroscience research communications, 20(1), 1997, pp. 1-10
17. LOVE A; COTTER MA; CAMERON NE
    EFFECTS OF ALPHA-TOCOPHEROL ON NERVE-CONDUCTION VELOCITY AND REGENERATION FOLLOWING A FREEZE LESION IN IMMATURE DIABETIC RATS
    Naunyn-Schmiedeberg's archives of pharmacology
    
    A. Love et al., "EFFECTS OF ALPHA-TOCOPHEROL ON NERVE-CONDUCTION VELOCITY AND REGENERATION FOLLOWING A FREEZE LESION IN IMMATURE DIABETIC RATS", Naunyn-Schmiedeberg's archives of pharmacology, 355(1), 1997, pp. 126-130
18. SASAKI H; NAKA K; KISHI Y; FURUTA M; SANKE T; MUKOYAMA M; NANJO K
    THE ABSENCE OF SYNERGISM BETWEEN THE EFFECTS OF AN ALDOSE REDUCTASE INHIBITOR, EPALRESTAT, AND A VASODILATOR, CILOSTAZOL, ON THE NERVE-CONDUCTION SLOWING AND THE MYELINATED FIBER ATROPHY IN STREPTOZOTOCIN-INDUCED DIABETIC RATS
    Experimental neurology
    
    H. Sasaki et al., "THE ABSENCE OF SYNERGISM BETWEEN THE EFFECTS OF AN ALDOSE REDUCTASE INHIBITOR, EPALRESTAT, AND A VASODILATOR, CILOSTAZOL, ON THE NERVE-CONDUCTION SLOWING AND THE MYELINATED FIBER ATROPHY IN STREPTOZOTOCIN-INDUCED DIABETIC RATS", Experimental neurology, 146(2), 1997, pp. 466-470
19. CAMERON NE; COTTER MA
    METABOLIC AND VASCULAR FACTORS IN THE PATHOGENESIS OF DIABETIC NEUROPATHY
    Diabetes
    
    N.E. Cameron e M.A. Cotter, "METABOLIC AND VASCULAR FACTORS IN THE PATHOGENESIS OF DIABETIC NEUROPATHY", Diabetes, 46, 1997, pp. 31-37
20. DINES KC; COTTER MA; CAMERON NE
    EFFECTIVENESS OF NATURAL OILS AS SOURCES OF GAMMA-LINOLENIC ACID TO CORRECT PERIPHERAL-NERVE CONDUCTION-VELOCITY ABNORMALITIES IN DIABETIC RATS - MODULATION BY THROMBOXANE A(2) INHIBITION
    Prostaglandins, leukotrienes and essential fatty acids
    
    K.C. Dines et al., "EFFECTIVENESS OF NATURAL OILS AS SOURCES OF GAMMA-LINOLENIC ACID TO CORRECT PERIPHERAL-NERVE CONDUCTION-VELOCITY ABNORMALITIES IN DIABETIC RATS - MODULATION BY THROMBOXANE A(2) INHIBITION", Prostaglandins, leukotrienes and essential fatty acids, 55(3), 1996, pp. 159-165
21. NICKANDER KK; MCPHEE BR; LOW PA; TRITSCHLER H
    ALPHA-LIPOIC ACID - ANTIOXIDANT POTENCY AGAINST LIPID-PEROXIDATION OFNEURAL TISSUES IN-VITRO AND IMPLICATIONS FOR DIABETIC NEUROPATHY
    Free radical biology & medicine
    
    K.K. Nickander et al., "ALPHA-LIPOIC ACID - ANTIOXIDANT POTENCY AGAINST LIPID-PEROXIDATION OFNEURAL TISSUES IN-VITRO AND IMPLICATIONS FOR DIABETIC NEUROPATHY", Free radical biology & medicine, 21(5), 1996, pp. 631-639
22. BIESSELS G; GISPEN WH
    THE CALCIUM HYPOTHESIS OF BRAIN AGING AND NEURODEGENERATIVE DISORDERS- SIGNIFICANCE IN DIABETIC NEUROPATHY
    Life sciences
    
    G. Biessels e W.H. Gispen, "THE CALCIUM HYPOTHESIS OF BRAIN AGING AND NEURODEGENERATIVE DISORDERS- SIGNIFICANCE IN DIABETIC NEUROPATHY", Life sciences, 59(5-6), 1996, pp. 379-387
23. LOVE A; COTTER MA; CAMERON NE
    EFFECTS OF THE SULFHYDRYL DONOR N-ACETYL-L-CYSTEINE ON NERVE-CONDUCTION, PERFUSION, MATURATION AND REGENERATION FOLLOWING FREEZE DAMAGE IN DIABETIC RATS
    European journal of clinical investigation
    
    A. Love et al., "EFFECTS OF THE SULFHYDRYL DONOR N-ACETYL-L-CYSTEINE ON NERVE-CONDUCTION, PERFUSION, MATURATION AND REGENERATION FOLLOWING FREEZE DAMAGE IN DIABETIC RATS", European journal of clinical investigation, 26(8), 1996, pp. 698-706
24. CAMERON NE; COTTER MA; HOHMAN TC
    INTERACTIONS BETWEEN ESSENTIAL FATTY-ACID, PROSTANOID, POLYOL PATHWAYAND NITRIC-OXIDE MECHANISMS IN THE NEUROVASCULAR DEFICIT OF DIABETIC RATS
    Diabetologia
    
    N.E. Cameron et al., "INTERACTIONS BETWEEN ESSENTIAL FATTY-ACID, PROSTANOID, POLYOL PATHWAYAND NITRIC-OXIDE MECHANISMS IN THE NEUROVASCULAR DEFICIT OF DIABETIC RATS", Diabetologia, 39(2), 1996, pp. 172-182
25. LOW PA; SUAREZ GA
    DIABETIC NEUROPATHIES
    Bailliere's clinical neurology
    
    P.A. Low e G.A. Suarez, "DIABETIC NEUROPATHIES", Bailliere's clinical neurology, 4(3), 1995, pp. 401-425
26. KIHARA M; LOW PA
    VASOREACTIVITY TO PROSTAGLANDINS OF RAT PERIPHERAL-NERVE
    Journal of physiology
    
    M. Kihara e P.A. Low, "VASOREACTIVITY TO PROSTAGLANDINS OF RAT PERIPHERAL-NERVE", Journal of physiology, 484(2), 1995, pp. 463-467
27. KIHARA M; SCHMELZER JD; LOW PA
    EFFECT OF CILOSTAZOL ON EXPERIMENTAL DIABETIC NEUROPATHY IN THE RAT
    Diabetologia
    
    M. Kihara et al., "EFFECT OF CILOSTAZOL ON EXPERIMENTAL DIABETIC NEUROPATHY IN THE RAT", Diabetologia, 38(8), 1995, pp. 914-918
28. COTTER MA; LOVE A; WATT MJ; CAMERON NE; DINES KC
    EFFECTS OF NATURAL FREE-RADICAL SCAVENGERS ON PERIPHERAL-NERVE AND NEUROVASCULAR FUNCTION IN DIABETIC RATS
    Diabetologia
    
    M.A. Cotter et al., "EFFECTS OF NATURAL FREE-RADICAL SCAVENGERS ON PERIPHERAL-NERVE AND NEUROVASCULAR FUNCTION IN DIABETIC RATS", Diabetologia, 38(11), 1995, pp. 1285-1294
29. CAMERON NE; COTTER MA; ARCHIBALD V; DINES KC; MAXFIELD EK
    ANTIOXIDANT AND PROOXIDANT EFFECTS ON NERVE-CONDUCTION VELOCITY, ENDONEURIAL BLOOD-FLOW AND OXYGEN-TENSION IN NONDIABETIC AND STREPTOZOTOCIN-DIABETIC RATS
    Diabetologia
    
    N.E. Cameron et al., "ANTIOXIDANT AND PROOXIDANT EFFECTS ON NERVE-CONDUCTION VELOCITY, ENDONEURIAL BLOOD-FLOW AND OXYGEN-TENSION IN NONDIABETIC AND STREPTOZOTOCIN-DIABETIC RATS", Diabetologia, 37(5), 1994, pp. 449-459
30. STEVENS EJ; CARRINGTON AL; TOMLINSON DR
    NERVE ISCHEMIA IN DIABETIC RATS - TIME-COURSE OF DEVELOPMENT, EFFECT OF INSULIN-TREATMENT PLUS COMPARISON OF STREPTOZOTOCIN AND BB MODELS
    Diabetologia
    
    E.J. Stevens et al., "NERVE ISCHEMIA IN DIABETIC RATS - TIME-COURSE OF DEVELOPMENT, EFFECT OF INSULIN-TREATMENT PLUS COMPARISON OF STREPTOZOTOCIN AND BB MODELS", Diabetologia, 37(1), 1994, pp. 43-48
31. WRIGHT RA; NUKADA H
    VASCULAR AND METABOLIC FACTORS IN THE PATHOGENESIS OF EXPERIMENTAL DIABETIC NEUROPATHY IN MATURE RATS
    Brain
    
    R.A. Wright e H. Nukada, "VASCULAR AND METABOLIC FACTORS IN THE PATHOGENESIS OF EXPERIMENTAL DIABETIC NEUROPATHY IN MATURE RATS", Brain, 117, 1994, pp. 1395-1407